New imaging system to help plan liver surgery
Part of Cancer, Digestive system clinical trials.
This trial tests a new imaging system to help surgeons plan liver removal operations. If you have a liver tumor that can be removed, this study may help improve surgical accuracy and outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old.
- You must have a liver tumor that can be removed with surgery.
- You must be in good general health and able to do your usual activities without help.
- Your liver function must be good (classified as Child-Pugh A) and your blood counts and kidney function must be within certain limits.
- You must not have cancer that has spread outside the liver, and no cancer treatments within the last 28 days.
- You must not have significant bleeding risk, severe lung disease, or poorly controlled diabetes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special 3D ultrasound scan (using contrast) can help support decisions for people with colorectal cancer that has spread to the liver. If you have planned new cancer treatment, the scan may add information to help doctors guide care.
This study uses MRI imaging and computer modeling to better plan liver surgery and related liver treatments. It may help doctors predict circulation (blood flow) changes during surgery and choose safer surgical timing or approaches.
This trial tests a new imaging technique that uses a special dye combined with a chemotherapy drug to help surgeons see and remove liver cancer more precisely during surgery. It is for people with a first-time, single liver tumor that is small and can be surgically removed.
This trial tests a new way to control blood flow during laparoscopic liver surgery. It compares two methods to see which is safer and more effective for patients with certain liver conditions.
This trial tests a new way to help surgeons see liver tumors more clearly during keyhole (laparoscopic) surgery. A special dye (ICG) is used with a camera to guide the surgeon in removing just the right part of the liver. It may lead to safer and more precise surgery for people with liver cancer.
This trial tests whether using augmented reality (AR) – a technology that overlays digital images onto the real world – during liver tumor surgery is safe and practical. It aims to help surgeons remove tumors more precisely, which could lead to better outcomes for you.
Hear when a new Liver Tumor; Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.